Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery
Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
This research will evaluate the efficacy of Omidria and Dexycu, Omidria and Dextenza, and
Omidria and prednisolone acetate 1% in the resolution of post-operative inflammation and pain
following cataract surgery.